Stock Region Watchlist
What’s on The Radar This Week?
Tech Giants & Healthcare Powerhouses
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: Hey everyone, before we dive in, please remember that this newsletter is for informational and entertainment purposes only. I’m just a market enthusiast sharing my personal thoughts and what I’m watching. This is not financial advice, and you should always do your own research before making any investment decisions.
What’s on The Radar This Week?
What a week in the markets! The big tech names are flexing their muscles, and it’s impossible to ignore the AI wave they’re all riding. At the same time, some healthcare giants are proving that slow and steady can still be incredibly powerful. Here’s a look at what’s caught my eye for Thursday, October 30th.
The Tech Titans: AI is the Name of the Game
It feels like you can’t talk about the market without mentioning Artificial Intelligence, and this week’s earnings reports show exactly why.
Alphabet ($GOOGL)
Wow. Just, wow. Alphabet came out with Q3 earnings that were simply stunning. We’re talking revenue of $102.4 billion, blowing past what analysts expected. To me, the real story is Google Cloud, which saw its revenue jump 34%. This isn’t just random growth; it’s being fueled by huge demand for their AI services. Companies are lining up for Google’s AI, and it shows. Alphabet is doubling down, boosting its spending forecast to $92 billion to build out its AI infrastructure. When a company invests that heavily in its future, I pay attention.
Microsoft ($MSFT)
Microsoft is another beast that just keeps on growing. Its Azure cloud service expanded by a massive 40%. It’s clear that the cloud wars are still raging, and Microsoft is a dominant force. What I find fascinating is their partnership with OpenAI. That $13 billion investment is looking smarter by the day, creating a powerful loop where OpenAI uses Azure, driving even more growth for Microsoft. It’s a bold, symbiotic relationship that seems to be paying off beautifully for them.
Meta Platforms ($META)
Meta isn’t getting left behind in the AI race. They recently announced a $10 billion deal with Google Cloud, which tells me they are dead serious about boosting their AI capabilities. It seems Meta is using AI to refine everything from its ad targeting to the user experience on its platforms. It’s a smart defensive and offensive move to stay competitive in a space where innovation is everything.
The Healthcare Stalwarts: Quiet Strength
While tech gets the flashy headlines, I’m also watching a couple of healthcare names that offer a different kind of strength: innovation and stability.
Eli Lilly ($LLY)
Eli Lilly has been a star for a while now, and for good reason. Their work in diabetes and obesity treatments is groundbreaking. It’s not just about one successful drug; it’s about a consistent pipeline of innovation that keeps them at the forefront of the pharmaceutical industry. This isn’t a stock you watch for wild daily swings, but for its steady leadership. For the short-term traders out there, the levels I’m watching are a potential breakout above $858.03 or a breakdown below $839.05.
Merck ($MRK)
Similar to Lilly, Merck is a story of consistent performance. Their oncology division, led by the blockbuster drug Keytruda, continues to be a massive growth driver. Cancer treatment is a field that will always need innovation, and Merck is a leader there. For investors who appreciate a strong, stable company with a portfolio of essential products, Merck is definitely one to keep on the watchlist. It’s a reminder that not all great stocks have to be in the tech sector.
That’s all for today! It’s a fascinating time to be watching the markets. The battle for AI dominance is heating up, while healthcare continues to provide a foundation of steady growth.
Stay sharp and happy trading,
The Stock Region Team
Final Disclaimer: All investments carry risk. The information provided in this newsletter is not a recommendation to buy or sell any security. All views expressed are personal opinions and should not be taken as financial advice. Please consult with a licensed financial professional before making any investment decisions.
Solid breakdown of Alphabet here. I think you're spot on that Google Cloud is the real story - 34% growth is absolutly wild for a business that's already at scale. What I find particularly intresting is the way you framed the $92B spending forecast. A lot of investors are freaking out about that number, but like you said, when a company invests that heavily in infrastructure, it usually means they're seeing real customer demand and not just speculative bets. The fact that companies are "lining up" for Google's AI services is exactly right - they're building moats through CapEx that will be really hard for smaller players to compete with. I'm also curious about your take on the regulatory overhang with the DOJ case. Alphabet's earnings are clearly firing on all cylinders, but there's this whole antitrust thing hanging over the search business. Do you think the market is already pricing in a worst-case scenario there, or is that still a potential risk that could surprise investors? Also, I think the comparison you drew between the flashy tech growth and the steady healthcare names was really smart - it's a good reminder that diversifcation across sectors can smooth out volatility.